ArticleCell communication and signaling : CCS2024

Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib).

Magdalena Kot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.